Clinical experience with cefoxitin sodium in immunologically compromised patients

Cefoxitin sodium was given to 30 patients with various moderate and severe infec-tions. Eighteen of these had impaired immune response resulting from either the primary disease or from concomitant immunosuppressive treatment. The drug was generally well tolerated. Mild toxicity could not be attributed to cefoxitin with certainty. Clinically, the response was excellent, although these patients were severely ill because of infections superimposed on various neoplastic diseases. Cefoxitin was proven to be an effective and safe drug